The Claim
In older adults with low-grade chronic inflammation, serum interleukin-10 levels are inversely associated with the concentrations of EPA-, DPA-, and DHA-derived lipid mediators including 18-HEPE, 12-HEPE, 5-HEPE, Rv5DPA, and 4-HDHA.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In older adults with persistent low-level inflammation, higher levels of interleukin-10 in the blood are consistently linked to lower levels of specific lipid molecules derived from omega-3 fatty acids.
See the scientific wording
In older adults with low-grade chronic inflammation, serum interleukin-10 levels are inversely associated with multiple EPA-, DPA-, and DHA-derived lipid mediators including 18-HEPE, 12-HEPE, 5-HEPE, Rv5DPA, and 4-HDHA, suggesting these mediators may be involved in modulating anti-inflammatory signaling pathways.
When omega-3 fats from food enter the body, they get turned into special molecules that attach to immune cell receptors, turning off a key inflammation switch called NF-κB. This reduces the production of inflammatory signals, and as a result, the body makes less of the calming signal IL-10 because it no longer needs to compensate for high inflammation.
What the research says
1 studyIn older people with long-term inflammation, higher levels of certain omega-3-derived molecules (like 18-HEPE and Rv5DPA) were linked to lower levels of IL-10, a protein that calms inflammation — meaning these molecules might be part of a subtle balancing act in the immune system.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.